基本信息
views: 235
Career Trajectory
Bio
Early in his career, he focused on the first-in-human applications of gene therapy for genetic diseases such as severe combined immunodeficiency (SCID) and research into gene therapy for hemophilia. He also led major research efforts into the application of gene therapy for infectious disease, specifically on HIV/AIDS, including one of the first clinical trials testing anti-HIV gene therapy in humans.
Research Interests
Papers共 315 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Tyler F. Hill,Parnal Narvekar, Gregory D. Asher,Jasmine N. Edelstein,Nathan D. Camp, Annaiz Grimm,Kerri R. Thomas, Michael D. Leiken, Katherine M. Molloy,Peter J. Cook,Sean P. Arlauckas,Richard A. Morgan,Sarah K. Tasian,David J. Rawlings,Richard G. James
Molecular therapy the journal of the American Society of Gene Therapyno. 8 (2024): 2676-2691
crossref(2023)
Jasmine Edelstein, Thomas J. Hill, Michael D Leiken, Katherine Molloy, Glory Adekanye,Caroline Bullock,Adam S. Lazorchak, Ken‐Edwin Aryee,David J. Rawlings,Richard G. James,Richard A. Morgan,Sean P. Arlauckas
Regular and Young Investigator Award Abstracts (2023)
crossref(2023)
Dhanalakshmi Chinnasamy,Eric Tran,Zhiya Yu,Richard A. Morgan,Nicholas P. Restifo, Steven A. Rosenberg
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
Richard A Morgan,David J Rawlings,Richard G James,Jasmine N Edelstein,Tyler F Hill, Michael D Leiken, Katherine M Molloy, Glory Adekanye,Caroline Bullock,Adam S Lazorchak, Ken-Edwin Aryee,Sean P Arlauckas
Journal for ImmunoTherapy of Cancerno. Suppl 1 (2023)
Load More
Author Statistics
#Papers: 314
#Citation: 48442
H-Index: 85
G-Index: 220
Sociability: 7
Diversity: 0
Activity: 1
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn